GlassScriptPhysician profile
Jeffrey Dixon
NPI 1669463865
$1,128.27
in general payments reported to CMS, 2019-2025
9 companies · $225 in 2025
The $225 reported for 2025 was more than what 84% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.16 · 2020: $224 · 2021: $29.44 · 2022: $239 · 2023: $330 · 2024: $16.00 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $543.46 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $154.15 | 2021-2025 | |
| Genentech, INC. | $144.27 | 2025 | |
| Abbvie INC. | $123.93 | 2023 | Dalvance |
| Melinta Therapeutics, LLC | $68.57 | 2019-2022 | |
| Vapotherm INC | $36.29 | 2020 | |
| Janssen Pharmaceuticals, INC | $32.77 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $13.27 | 2019 | |
| Chiesi USA, INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.